Covalent Modification of Ataxin-3 by SUMO-1
DOI:
Author:
Affiliation:

Clc Number:

Fund Project:

This work was supported by grants from The National Natural Science Foundation of China (30070273, 30470619), Hi-Tech Research Development Program of China (2001AA227011, 2004AA227040), and The Special Funds of Major State Basic Research of China (2004BA720A03).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    In order to get insight into the biological function of ataxin-3 and the pathogenesis of spinocerebellar ataxia type 3 and Machado-Joseph disease (SCA3/MJD) , a yeast two-hybrid technology was carried out to screen the adult brain cDNA library using the full-length polyglutamine-expanded ataxin-3 as bait . Small ubiquitin-like modifier 1(SUMO-1) was identified as a novel ataxin-3-interacting protein. Subsequently, co-immunoprecipitation showed that both the wild-type ataxin-3 and the polyglutamine-expanded ataxin-3 were covalently modified by SUMO-1 in SH-SY5Y cell; immunofluorescence showed that the intranuclear aggregates formatted by the polyglutamine-expanded ataxin-3 co-localized with SUMO-1. Taken together, the data suggest that the biological function of ataxin-3 may be regulated by SUMO-1, and that SUMO-1 may participate in the pathogenesis of SCA3/MJD.

    Reference
    Related
    Cited by
Get Citation

TANG Jian-Guang, SHEN Lu, TANG Bei-Sha, ZHANG Yu-Hu, JIANG Hong, LIAO Shu-Sheng, ZHANG Hai-Nan, WANG Chun-Yu, XIA Kun, PAN Qian. Covalent Modification of Ataxin-3 by SUMO-1[J]. Progress in Biochemistry and Biophysics,2006,33(11):1037-1043

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:May 22,2006
  • Revised:July 26,2006
  • Accepted:
  • Online: November 17,2006
  • Published: